Lee Patterson joins UK-based Charnwood Molecular as new CEO. After nearly 25 years at UK-based Charnwood Molecular, Prof. Steve Allin has stepping down as CEO. He will remain as an investor and Board advisor.
The biopharmaceutical company Biomunex Pharmaceuticals announces the appointment of Dr Simon Plyte as Chief Scientific Officer (CSO) and as a member of its scientific advisory board.
VIB and Flemish Minister of Economy and Innovation, Hilde Crevits, announce the appointment of Dr Christine Durinx as VIB’s co-managing director, alongside Dr Jérôme Van Biervliet. Dr Jo Bury, co-founder and co-managing director since VIB’s inception 25 years ago, is passing the torch to Durinx who is the former Executive Director of the SIB Swiss Institute of Bioinformatics.
The Swedish chief epidemiologist Anders Tegnell plans to move to the World Health Organisation (WHO) in Geneva.
Maja Neiman is the first Science Relations Manager at SwedenBIO. The biotechnologist started her work at the end of March.
Since the beginning of March, Dr Neil Torbett has been the new Chief Executive Officer of Cambridge-based PhoreMost Ltd.
Barcelona-based Integra Therapeutics appoints George Church to its Scientific Advisory Board.
InDex Pharmaceuticals needs a new COO. After ten years as Chief Operating Officer, Pernilla Sandwall will leave the Stockolm-based company at the end of April.
Laurence Riot Lamotte has started at the beginning of 2022 als new Chief Financial Officer of French Diaccurate. She succeeds José Da Gloria, who left the company.
Co-founder and former board member of Galapagos NV Dr Paul Stoffels will take over the position of Chief Executive Officer at the Belgian company from April. He succeeds long-time CEO Onno van de Stolpe, who is retiring.